156 related articles for article (PubMed ID: 8255008)
21. The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial.
Yang D; He L; Peng X; Liu H; Peng Y; Yuan S; Liu Y; Chen X; Liu F; Liu C
Ren Fail; 2016; 38(2):242-8. PubMed ID: 26727697
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
Ogura S; Moriyama T; Miyabe Y; Karasawa K; Nitta K
Clin Exp Nephrol; 2021 Oct; 25(10):1103-1110. PubMed ID: 34101029
[TBL] [Abstract][Full Text] [Related]
23. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG; Yu SH; Owen JE; Kincaid-Smith P
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of tonsillectomy in patients with IgA nephropathy.
Akagi H; Nishizaki K; Hattori K; Kosaka M; Fukushima K; Doi A; Masuda Y
Acta Otolaryngol Suppl; 1999; 540():64-6. PubMed ID: 10445082
[TBL] [Abstract][Full Text] [Related]
25. Add-On Effect of Angiotensin Receptor Blockade (Candesartan) on Clinical Remission in Active IgA Nephropathy Patients Treated with Steroid Pulse Therapy and Tonsillectomy: a Randomized, Parallel-Group Comparison Trial.
Kohagura K; Arima H; Miyasato H; Chang TH; Yamazato M; Kobori H; Nishiyama A; Iseki K; Ohya Y
Kidney Blood Press Res; 2018; 43(3):780-792. PubMed ID: 29794482
[TBL] [Abstract][Full Text] [Related]
26. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[TBL] [Abstract][Full Text] [Related]
27. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
Kennoki T; Ishida H; Yamaguchi Y; Tanabe K
Transplantation; 2009 Oct; 88(7):935-41. PubMed ID: 19935466
[TBL] [Abstract][Full Text] [Related]
28. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Woo KT; Lee GS; Lau YK; Chiang GS; Lim CH
Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy.
Kawasaki Y; Takano K; Suyama K; Isome M; Suzuki H; Sakuma H; Fujiki T; Suzuki H; Hosoya M
Pediatr Nephrol; 2006 Nov; 21(11):1701-6. PubMed ID: 16932894
[TBL] [Abstract][Full Text] [Related]
30. Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin A nephropathy.
Katafuchi R; Kawamura T; Joh K; Hashiguchi A; Hisano S; Shimizu A; Miyazaki Y; Nagata M; Matsuo S;
Clin Exp Nephrol; 2016 Apr; 20(2):244-52. PubMed ID: 26349433
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and limitations of additional steroid pulse therapy in IgA nephropathy patients whose hematuria did not remit on tonsillectomy and protocol steroid pulse therapy.
Toda M; Kume A; Hara M; Kimura H; Nakamura Y; Okumura K; Beppu H; Nakamura Y; Ogawa H; Kamei Y; Ishiwatari A; Kawanishi T; Ogawa T; Abe Y; Endo M; Wakai S
Clin Exp Nephrol; 2022 Sep; 26(9):859-866. PubMed ID: 35486336
[TBL] [Abstract][Full Text] [Related]
32. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.
Kawamura T; Yoshimura M; Miyazaki Y; Okamoto H; Kimura K; Hirano K; Matsushima M; Utsunomiya Y; Ogura M; Yokoo T; Okonogi H; Ishii T; Hamaguchi A; Ueda H; Furusu A; Horikoshi S; Suzuki Y; Shibata T; Yasuda T; Shirai S; Imasawa T; Kanozawa K; Wada A; Yamaji I; Miura N; Imai H; Kasai K; Soma J; Fujimoto S; Matsuo S; Tomino Y;
Nephrol Dial Transplant; 2014 Aug; 29(8):1546-53. PubMed ID: 24596084
[TBL] [Abstract][Full Text] [Related]
33. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
34. Effects of tonsillectomy in children with IgA nephropathy, purpura nephritis, or other chronic glomerulonephritides.
Sanai A; Kudoh F
Acta Otolaryngol Suppl; 1996; 523():172-4. PubMed ID: 9082773
[TBL] [Abstract][Full Text] [Related]
35. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
36. Utility of remission criteria for the renal prognosis of IgA nephropathy.
Matsuzaki K; Suzuki H; Kawamura T; Tomino Y; Suzuki Y
Clin Exp Nephrol; 2021 Sep; 25(9):988-995. PubMed ID: 33974158
[TBL] [Abstract][Full Text] [Related]
37. Remission of proteinuria improves prognosis in IgA nephropathy.
Reich HN; Troyanov S; Scholey JW; Cattran DC;
J Am Soc Nephrol; 2007 Dec; 18(12):3177-83. PubMed ID: 17978307
[TBL] [Abstract][Full Text] [Related]
38. Outcome of tonsillectomy for recurrent IgA nephropathy after kidney transplantation.
Koshino K; Ushigome H; Sakai K; Suzuki T; Nobori S; Okajima H; Masuzawa N; Yoshimura N
Clin Transplant; 2013; 27 Suppl 26():22-8. PubMed ID: 24299232
[TBL] [Abstract][Full Text] [Related]
39. [Does tonsillectomy cause any change in long-term course of IgA nephropathy?].
Barta J; Kovács T; Fazekas A; Jeges S; Nagy G; Nagy J
Orv Hetil; 1996 Dec; 137(52):2903-6. PubMed ID: 9254343
[TBL] [Abstract][Full Text] [Related]
40. Comparison of methods of steroid administration combined with tonsillectomy for IgA nephropathy patients.
Watanabe H; Goto S; Kondo D; Takata T; Yamazaki H; Hosojima M; Yamamoto S; Kaneko Y; Aoyagi R; Narita I
Clin Exp Nephrol; 2017 Apr; 21(2):257-265. PubMed ID: 27216016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
